# Densitas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/densitas

- Industry: Medical Devices & Equipment
- Headquarters: Halifax, Canada
- Website: www.densitas.ca
- Total disclosed funding: $0.3M
- Latest round: Seed (Oct 23, 2015)
- Investors on record: 1

## About

Densitas specializes in advanced analytics solutions for breast imaging, utilizing artificial intelligence for standardized breast density assessments and quality tracking in mammography services.Founded in 2011, Densitas is based in Halifax, Canada, and focuses on developing analytics solutions for breast imaging. The company raised USD 0.25 million in Seed funding in October 2015 from Invest Nova Scotia. Mo Abdolell serves as the CEO.Densitas offers advanced analytics solutions primarily through its flagship product, the Densitas intelliMammo® platform. This platform utilizes artificial intelligence to automate and standardize breast density assessments, aligning with the American College of Radiology (ACR) 5th edition guidance. It enables comprehensive mammography quality tracking, including image quality reviews and compliance with the Mammography Quality Standards Act (MQSA) EQUIP requirements. The system serves various end-users, including radiologists, technologists, and breast imaging facilities, improving operational efficiencies and enhancing patient care by providing personalized breast density measures and cancer risk assessments. Densitas solutions are marketed across North America, Europe, and specifically Germany, where their densityai™ software is deployed in clinics for breast cancer screening trials.Densitas generates revenue through strategic partnerships, subscriptions, and direct sales of its software solutions to healthcare facilities. The primary revenue stream comes from licensing the intelliMammo® platform, utilized by hospitals and outpatient imaging centers to improve mammography services. Transactions typically involve a subscription model for ongoing access to the analytics platform, with additional fees for specialized features or training materials, tailored to meet the needs of healthcare organizations.Densitas plans to leverage the recent USD 0.25 million raised in Seed funding from Innovacorp to enhance its product offerings and expand into new markets. The company is working on new features for the intelliMammo® platform, targeting broader deployment in North America and Europe by the end of 2023.

## Funding rounds

- Seed, Oct 23, 2015, $0.3M — Invest Nova Scotia

## Investors

- Invest Nova Scotia — Seed